Back to search

Article

Reporting Disproportionality of Breast Cancer-Related Adverse Events Across Quinone- and Hydroquinone-Type Vitamin K Homologs in the FDA Adverse Event Reporting System

2026-05-15

Abstract excerpt

<h4>Background: </h4> /Objective: Vitamin K (VK) comprises a family of quinone compounds with potential involvement in cell death-related pathways through their redox properties. However, consistent findings have not been obtained regarding the clinical significance of VK in breast cancer (BC). Thus, we used the FDA Adverse Event Reporting System (FAERS) to examine the co-reporting patterns of BC-related adverse-e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
053d8ee7-16b7-5d94-b335-65cd49bbc4c0
DOI
10.20944/preprints202605.1006.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reporting Disproportionality of Breast Cancer-Related Adverse Events Across Quinone- and Hydroquinone-Type Vitamin K Homologs in the FDA Adverse Event Reporting SystemDOI 10.20944/preprints202605.1006.v1
Select a neighboring publication to make it the new centre.